We are live on ! Find out more
BCM

Bourgeon Capital Management Portfolio holdings

AUM $679M
1-Year Est. Return 50.89%
This Fund
S&P 500
This Quarter Est. Return
+14.67%
1 Year Est. Return
+50.89%
3 Year Est. Return
+117.43%
5 Year Est. Return
+128.86%
10 Year Est. Return
+553.89%
AUM
$507M
AUM Growth
+$42.1M
Cap. Flow
-$10.8M
Cap. Flow %
-2.12%
Top 10 Hldgs %
33.63%
Holding
122
New
17
Increased
39
Reduced
39
Closed
15

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$9.29M
2
CFLT
Confluent
CFLT
+$7.23M
3
VST icon
Vistra
VST
+$6.32M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$5.86M
5
ILMN icon
Illumina
ILMN
+$4.99M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$11.6M
2
EQT icon
EQT Corp
EQT
+$11M
3
AMGN icon
Amgen
AMGN
+$10.3M
4
EPD icon
Enterprise Products Partners
EPD
+$6.61M
5
PWR icon
Quanta Services
PWR
+$6.22M

Sector Composition

Rank Sector Weight
1 Technology 25.84%
2 Industrials 15.35%
3 Financials 14.52%
4 Healthcare 13.67%
5 Energy 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSX icon
101
Boston Scientific
BSX
$70.2B
$242K 0.05%
+2,252
New +$228K
EW icon
102
Edwards Lifesciences
EW
$51.1B
$235K 0.05%
3,007
-11
-0.4% -$820
DLR icon
103
Digital Realty Trust
DLR
$70.8B
$228K 0.05%
+1,307
New +$214K
WPC icon
104
W.P. Carey
WPC
$16.6B
$206K 0.04%
3,300
– –
APH icon
105
Amphenol
APH
$201B
$202K 0.04%
+2,046
New +$167K
CC icon
106
Chemours
CC
$2.57B
$180K 0.04%
15,750
-18,250
-54% -$206K
ALLO icon
107
Allogene Therapeutics
ALLO
$635M
$124K 0.02%
+110,000
New +$146K
AA icon
108
Alcoa
AA
$11.8B
– –
-187,534
Closed -$5.72M
ARE icon
109
Alexandria Real Estate Equities
ARE
$9.24B
– –
-45,381
Closed -$4.2M
ASLE icon
110
AerSale
ASLE
$307M
– –
-37,091
Closed -$278K
CEG icon
111
Constellation Energy
CEG
$97.7B
– –
-26,193
Closed -$5.28M
EPD icon
112
Enterprise Products Partners
EPD
$81.9B
– –
-193,554
Closed -$6.61M
EQT icon
113
EQT Corp
EQT
$33.5B
– –
-206,016
Closed -$11M
GRID
114
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund
GRID
$11.8B
– –
-3,502
Closed -$396K
IBB icon
115
iShares Biotechnology ETF
IBB
$9.18B
– –
-4,424
Closed -$566K
MCHP icon
116
Microchip Technology
MCHP
$40.8B
– –
-8,707
Closed -$422K
NEE icon
117
NextEra Energy
NEE
$181B
– –
-48,453
Closed -$3.43M
NXPI icon
118
NXP Semiconductors
NXPI
$56.5B
– –
-1,518
Closed -$289K
OIH icon
119
VanEck Oil Services ETF
OIH
$1.89B
– –
-2,024
Closed -$531K
SONY icon
120
Sony
SONY
$133B
– –
-26,553
Closed -$674K
UNH icon
121
UnitedHealth
UNH
$377B
– –
-22,106
Closed -$11.6M
XBI icon
122
State Street SPDR S&P Biotech ETF
XBI
$9.62B
– –
-2,822
Closed -$229K
1 2 3 4
5

Similar funds

AP
Advisors Preferred Rockville, Maryland $679M AUM 22.19% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
REAM
Ripple Effect Asset Management New York $679M AUM 81.6% 1-Year Est. Return
CCG
Clearlake Capital Group Santa Monica, California $680M AUM 30.34% 1-Year Est. Return
DLIC
Daido Life Insurance Company Osaka, Japan $678M AUM 16.09% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $678M AUM 13.87% 1-Year Est. Return
CIA
Covington Investment Advisors Ligonier, Pennsylvania $680M AUM 28.91% 1-Year Est. Return
NS
Night Squared New York $681M AUM 50% 1-Year Est. Return

Bourgeon Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Bourgeon Capital Management held 122 positions worth $507M, up 9.1% from $465M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Bourgeon Capital Management's Q2 2025 filing shows 17 new, 39 increased, 39 reduced and 15 closed positions. Its largest new stake was Confluent: 320,621 shares worth $7.99M. The largest sale was UnitedHealth, an estimated $11.6M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 21% a quarter earlier, followed by Industrials and Financials.

  • Bourgeon Capital Management's largest Q2 2025 buy was Confluent: 320,621 shares worth $7.99M.
  • Bourgeon Capital Management added most to Eli Lilly in Q2 2025, an estimated $9.29M increase.
  • Bourgeon Capital Management's biggest Q2 2025 reduction was Amgen, cutting an estimated $10.3M.
  • Bourgeon Capital Management fully exited UnitedHealth in Q2 2025, selling an estimated $11.6M.
  • Bourgeon Capital Management's ten largest holdings make up 34% of its $507M portfolio in Q2 2025.
  • Bourgeon Capital Management opened 17 new positions and closed 15 in Q2 2025.
  • Bourgeon Capital Management's portfolio value rose 9.1% quarter-over-quarter to $507M.

Based on Bourgeon Capital Management's 13F filing for Q2 2025, filed 18 Jul 2025.